Navigation Links
New mouse collaborative cross resource promises new cures and treatments for diseases
Date:2/16/2012

A new genetic resource from an international research consortium is expected to accelerate the development of new cures and treatments for a wide range of human diseases. This project, called the mouse "Collaborative Cross" (CC) resource, will increase the likelihood that experiments conducted in mice will advance our understanding of human biology. The mice in the CC have 90 percent of the genetic diversity present in laboratory mice, which mirrors the genetic diversity in humans. This will enable researchers to study traits and human diseases of complex origins in an appropriate model system.

Key findings arising from the CC will be published in February 2012 as a series of articles across both scientific journals published by the Genetics Society of America (GSA): GENETICS and G3: Genes|Genomes|Genetics. The 15 articles highlight the contributions of the CCand a companion mouse resource called the "Diversity Outbred" (DO) resourceto a number of important areas of human health. The MCC and DO are already shedding light on the genes influencing HDL cholesterol levels, systolic blood pressure, triglyceride levels, glucose, and variation in hematological traits like red and white blood cell counts, reactions to the influenza A virus, and mouse brain reaction to clozapine, a drug used for schizophrenia.

According to Dr. Fernando Pardo-Manuel de Villena (University of North Carolina at Chapel Hill Department of Genetics and Lineberger Comprehensive Cancer Center), one of the primary leaders of the CC, "A common complaint about using animal models has been the fact that some research doesn't carry over when applied to humans. The Collaborative Cross resource hopes to answer this complaint."

"Genetic causes may underlie many idiosyncratic adverse drug reactions," explained Dr. Gary Churchill (The Jackson Laboratory), another leader of the CC project. "Initial screening with this genetically diverse and heterogeneous model
'/>"/>

Contact: Phyllis Edelman
pedelman@genetics-gsa.org
301-634-7302
Genetics Society of America
Source:Eurekalert

Page: 1 2

Related biology news :

1. Sharp images from the living mouse brain
2. Multiple births lead to weight gain and other problems for mouse moms and male offspring
3. Severe congenital disorder successfully treated in a mouse model for the first time
4. Cleft lip corrected genetically in mouse model
5. Self-organized pituitary-like tissue from mouse ES cells
6. UCLA Engineering researchers help develop complete map of mouse genetic variation
7. Mouse genome sequences reveal variability, complex evolutionary history
8. A mouse model brings new perspectives on Lafora disease
9. Mouse virus erroneously linked to chronic fatigue syndrome, UCSF collaborative study finds
10. Of mice and men: UNC-led team solves mouse genome dilemma
11. What is a laboratory mouse? Jackson, UNC researchers reveal the details
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... , August 10, 2015 ... Eye Tracking Technology for more than two decades, announces ... for integration into all consumer display formats. The SMI ... integration of eye tracking into consumer tablets, laptops, desktop ... smart glasses. Omnivision,s leading sensor technology contributes to the ...
(Date:8/5/2015)... 2015 According to a new ... Software, Services, Vertical (BFSI, Airport, IT & Telecom, Utilities, ... Forecast to 2020", published by MarketsandMarkets, defines and segments ... various segments. The global PIAM Market is estimated to ... by 2019, at a CAGR of 14.9 % from ...
(Date:8/3/2015)... 3, 2015 Synaptics, Inc. (Nasdaq: SYNA ... announced that members of the executive management team will ... Global Technology Leadership Forum on Tuesday, August 11, 2015 ... held at the Sonnenalp Resort in Vail, ... include forward-looking information. An audio webcast of the event ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... and Biological Sciences Research Council (BBSRC) have opened up ... our ability to produce disease- and pest-resistant crops in ... July) in the journal Science . An ... the University of Warwick, has used a systems biology ...
... Continued reliance on a strategy of setting aside ... to stem global biodiversity loss, according to a comprehensive ... Progress Series . Despite impressively rapid growth of ... over 100,000 in number and covering 17 million square ...
... on an old solar cell design sends light ricocheting ... by 26 percent. By engineering alternating layers ... from the University of Minnesota has improved the efficiency ... as 26 percent. These cells, known as dye-sensitized solar ...
Cached Biology News:Plant immunity discovery boosts chances of disease-resistant crops 2Ongoing global biodiversity loss unstoppable with protected areas alone: Study 2Ongoing global biodiversity loss unstoppable with protected areas alone: Study 3Ongoing global biodiversity loss unstoppable with protected areas alone: Study 4
(Date:9/2/2015)... FRANCISCO, Calif. , Sept. 2, 2015 ... Bonnie H. Anderson , president and chief executive ... Conference on Wednesday, September 16, 2015 at 10:30 a.m. ... The live audio webcast and subsequent ... . The webcast will be available shortly after conclusion ...
(Date:9/2/2015)... ... September 02, 2015 , ... Whitehouse ... will be attending Pharma Ed Resources upcoming educational seminar and training session on ... speakers, this timely conference will provide Updates & Case Studies on the Latest ...
(Date:9/1/2015)... ... ... Spirax Sarco , the leader in products and services for steam ... This platform, offering unique online ordering capabilities, is only available to Spirax Sarco distributors. ... Spirax Sarco Anytime and within minutes you can be making your purchase. Distributors ...
(Date:9/1/2015)... ... 01, 2015 , ... In her thought provoking debut novel ‘ Ebola Vaccine ... future faced with an Ebola pandemic that is on the cusp of wiping out ... the world of counterterrorism, and who continues to appear in this series of books ...
Breaking Biology Technology:Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3Spirax Sarco Announces New Features to Anytime Platform 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3
... and CLAREMONT, Calif., Jan. 7 /Xinhua-PRNewswire-FirstCall/ --,Kiwa ... Xinjiang,Corps Agro-technology Extended Terminal promulgated the test ... and "Jin Peng Jia Bao", both of,which ... fertilizer,certificate replaces the previous Temporary Amino Acid ...
... England, January 7 /PRNewswire-FirstCall/,-- Evotec AG (Frankfurt Stock ... a Phase I safety and tolerability study with ... profile of EVT,302 and are an encouraging basis ... reversible and highly selective inhibitor of MAO-B in,development ...
... Incorporated,(Nasdaq: VICL ) today announced that Vijay ... a panel discussion on biodefense and,pandemic influenza Wednesday ... Francisco, CA - January 7-10)., The session ... & Aldridge LLP.,Co-keynotes for the session are Rajeev ...
Cached Biology Technology:Kiwa Fertilizers Pass Independent Tests 2Kiwa Fertilizers Pass Independent Tests 3Phase I Safety and Tolerability Study With EVT 302 Successfully Completed 2Phase I Safety and Tolerability Study With EVT 302 Successfully Completed 3Phase I Safety and Tolerability Study With EVT 302 Successfully Completed 4Phase I Safety and Tolerability Study With EVT 302 Successfully Completed 5Vical to Participate in Pandemic Influenza Panel at JPMorgan Healthcare Conference 2
One-step, microplate or cuvet, colorimetric, linear detection range 0.6 mM to 100 mM. Procedure: 2 min....
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
EnzChek cellulase substrate *blue fluorescent, 339/452...
Request Info...
Biology Products: